New user? / Forgot your password?
0 Item | 0,00 €
High-Purity Fenofibric Acid Reference Materials for Precise Residue Analysis
Ensure the highest accuracy in your food and environmental residue analysis with HPC Standards GmbHs high-purity Fenofibric Acid reference materials. Our products are rigorously tested to meet international quality requirements and the highest industrial standards, making them essential for laboratories dedicated to compliance and precision. Trust HPC Standards GmbH as your competent partner in delivering reliable analytical standards.
Product | Catalog No./ CAS No. | Quantity | Price | |
---|---|---|---|---|
D6-Fenofibric acid solution | 685440 | 1X1ML | ||
676362 | 1X10MG | Please log in. | ||
Fenofibric acid solution | 678366 | 1X1ML | Please log in. | |
691680 | 1X50MG | Please log in. |
High-quality reference materials for accurate residue analysis in food and environmental laboratories.
Fenofibric acid is a drug of the fibrate class mainly used to reduce cholesterol levels. It is a derivative of fenofibrate, which is used to treat abnormal blood lipid levels.
Fenofibric acid is primarily used for the treatment of primary hypercholesterolemia or mixed dyslipidemia. It may also slow the progression of diabetic retinopathy in patients with type 2 diabetes.
Fenofibric acid is available by prescription only in many countries, including the US, UK, and Australia. It is classified under various ATC codes such as C10AB05, C10BA03, and C10BA04.
Regular monitoring of liver function tests, renal function, and lipid levels is recommended for patients undergoing treatment with fenofibric acid.
Common side effects include liver problems, breathing problems, abdominal pain, muscle problems, and nausea. Serious side effects may include toxic epidermal necrolysis, rhabdomyolysis, gallstones, and pancreatitis.
Fenofibric acid has been identified in sludge samples from wastewater treatment plants, indicating its presence in the environment.
When administered with statins, it is recommended to take fenofibric acid in the morning and the statin at night to avoid peak dosage overlap. Regular monitoring of liver and renal functions is advised.
In 2016, the FDA withdrew approval for the coadministration of fenofibric acid with statins due to insufficient evidence supporting cardiovascular benefits.
HPC Standards GmbH provides high-purity reference materials for fenofibric acid, ensuring accurate and reliable residue analysis. Our products meet international quality requirements and the highest industrial standards.